ABSTRACT. The frequent inclusion of heparin in fluids used for total parenteral nutrition in infants, prompted an investigation of the ability of heparin to release lipoprotein lipase (LPL) and hepatic lipase (HL) from the endothelial surface into the circulation, and of the effect of heparin on tissue stores of lipase in the postnatal period. In rat pups, plasma postheparin lipolytic activity (PHLA) released by IP administration of heparin (0.5 unit/g body wt) was 15% of adult values at birth and increased rapidly to reach 60% on day 10. Repeated doses of heparin (in adult rats, given 0.1 unit/g IV) at 1 and 4 h after the initial dose did not affect the maximal response to heparin. In all age groups 80% of PHLA was inhibited by 0.5 M NaCl, suggesting a mostly nonhepatic origin for the released enzyme. Heart, lung, and liver lipase activities of rat pups were not significantly different from controls not given heparin. The pattern of change in tissue enzyme content was similar for heart and lung, but different from hepatic lipase. LPL activity in the former increased from 10 and 30% to 60 and 100% of adult values between birth and 10 days while in the latter enzyme activity exceeded adult levels at birth and decreased to 50% of adult values during the latter half of the suckling period (days 10-21). Our results demonstrate that heparin does not cause depletion of tissue lipases in the postnatal period. The parallel increases in LPL content of peripheral tissues and PHLA suggest that in all age groups heparin-induced release of LPL into the circulation is proportional to tissue lipolytic activity. The first step in the catabolism of circulating triglycerides occurs at the luminal surface of the capillary endothelium where lipoprotein lipase (in extrahepatic tissues) and hepatic lipase (in the liver) hydrolyze lipoprotein-triglyceride to free fatty acids and I1-ionoglyceride (10, 21, 22) . The endothelial enzymes are readily released into the circulation after heparin injection (1 7), where they are referred to as PHLA. Numerous studies, in
ABSTRACT. The frequent inclusion of heparin in fluids used for total parenteral nutrition in infants, prompted an investigation of the ability of heparin to release lipoprotein lipase (LPL) and hepatic lipase (HL) from the endothelial surface into the circulation, and of the effect of heparin on tissue stores of lipase in the postnatal period. In rat pups, plasma postheparin lipolytic activity (PHLA) released by IP administration of heparin (0.5 unit/g body wt) was 15% of adult values at birth and increased rapidly to reach 60% on day 10. Repeated doses of heparin (in adult rats, given 0.1 unit/g IV) at 1 and 4 h after the initial dose did not affect the maximal response to heparin. In all age groups 80% of PHLA was inhibited by 0.5 M NaCl, suggesting a mostly nonhepatic origin for the released enzyme. Heart, lung, and liver lipase activities of rat pups were not significantly different from controls not given heparin. The pattern of change in tissue enzyme content was similar for heart and lung, but different from hepatic lipase. LPL activity in the former increased from 10 and 30% to 60 and 100% of adult values between birth and 10 days while in the latter enzyme activity exceeded adult levels at birth and decreased to 50% of adult values during the latter half of the suckling period (days [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] isolated organs or intact animals, have shown that the easily accessible endothelial enzyme is directly related to triglyceride hydrolysis; its removal from the endothelium following heparin infusion completely abolishes the ability of isolated organs to hydrolyze infused lipoprotein-triglyceride (9, 21), whereas injection of antibodies against lipoprotein lipase is rapidly followed by marked hyperlipemia (1, 16). Thus, serum postheparin lipolytic activity provides an accurate measure of functional (endothelial) lipase concentrations. Since serum postheparin lipolytic activity is easily accessible, it has been extensively studied in humans (4, 6, lo), whereas animal studies have been limited mainly to adults. PHLA increases with gestational age; it is low in low birth weight premature infants (8) , as compared to term infants (14) . The developmental pattern of PHLA is of importance for the clinical management of very low birth weight infants, who are maintained on total parenteral nutrition containing Intralipid as the major energy source (23) . Some nurseries routinely include heparin (1 unitlml) in total parenteral nutrition solutions given to low birth weight infants. Since little is known about the long term effects of Intralipid in neonates and about the possible effects of heparin administration on tissue stores of lipid-clearing enzymes, we studied the effect of heparin on tissue lipase stores and on their release from the endothelial surface into the circulation. Since these tissue enzymes cannot be studied in humans, we measured postheparin lipolytic activity and the effect of heparin on lipoprotein lipase and hepatic lipase in the developing rat.
MATERIALS AND METHODS
Animals. Pregnant Sprague-Dawley rats were observed daily to determine the date of birth of the litters. The mothers and pups had free access to food throughout the experiment. The pups were studied at birth and at 3, 10, 14, 17, 21, 28, and 60 days. At 21 days after birth, the pups were separated from their mothers and the males and females were housed separately.
Administration of heparin to rats ages 1-28 days was by the IP route since it was technically difficult to give IV injections to very young animals. Following preliminary experiments, a dose of 0.5 unitlg body wt was chosen; with this dose, there was little or no bleeding, whereas smaller doses produced lower responses. Preliminary studies in weanling pups (days 21 and 28) have shown comparable levels of PHLA fol10,wing heparin administration by either IP or IV route. The animals were sacrificed by decapitation and blood was collected from cervical vessels. For experiments on older rats, 0.1 unit heparinlg body wt was given IV under pentobarbital anesthesia (50 mglkg), and blood was obtained from the tail vein or from the bifurcation of the aorta at the time of sacrifice. For lipase assay on tissues, the hearts, lungs, and livers were dissected, rinsed in ice-cold saline, and weighed before being homogenized in 0.025 M NH3-HCl buffer containing heparin, 4 units/ml. The stomachs were checked for the presence of food and weighed to ensure that all pups were fed. Organs weighing under 1 g were minced and used in their entirety, those weighing above 1 g were minced, and 1.0 g was taken for homogenization. Acetone powders were prepared as previously described (1 1).
Assays of lipolytic activities. The acetone powders were solubilized by rehomogenization in cold 0.025 M NH3-HCl buffer, pH 8.1, containing heparin, 4 units/ml. The lipolytic activities in both plasma and acetone powders were measured by hydrolysis of serum-activated t~i[~H]oleate as previously described (9), and expressed as pmol FFA produced/ml/h for plasma and nmol FFA produced/mg acetone powder/h for the tissues. The quantitative contribution of hepatic lipase and lipoprotein lipase to total PHLA was measured by assay of lipase activity in the presence or absence of 0.5 M NaCl. High ionic strength (achieved by 0.5 M NaCl) completely inhibits lipoprotein lipase, but has no effect on the activity of hepatic lipase (17) .
Statistical differences between groups were evaluated by Student's t test.
RESULTS
The time course of PHLA release after IP heparin administration to pups ages 3-17 days is presented in Figure 1 . Peak lipase activity was at 30 min after heparin administration with a return to baseline after 4 h, and was higher with increasing age.
Total PHLA increased rapidly between birth and 10 days of age and did not show further significant changes up to 28 days (Fig. 2) . The increase in PHLA activity between 28 and 60 days of age is probably associated with the marked increase in adipose tissue size, an organ rich in lipoprotein lipase. In all age groups, 80% of the lipolytic activity released into the circulation was inhibited by 0.5 M NaCl and can, therefore, be presumed to be of peripheral origin. The marked increase in heparin-releasable hepatic lipase between 28 and 60 days after birth (Fig. 2) is probably directly related to the 3-fold increase in hepatic lipase activity during this period (Fig. 4C) . No lipolytic activity was detected in plasma of rats not given heparin.
To assess the rate of replenishment of endothelial lipoprotein lipase after its release by injection of heparin into the circulation, we measured the level of PHLA after repeated bolus heparin injections. In 60-day-old rats given heparin IV (0.10 unit/g), *... Time ( m i d Fig. 3 . Effect of repeated heparin administration (0.1 unit/g IV) on peak postheparin lipolytic activity levels. Blood was obtained from the tail vein at each time point studied. PHLA was quantitated in 20 pl serum as described previously (9) . The data are means of three experiments. Mean initial PHLA level was 53 pmol FFA released/ml serum/h (range, 40-58 pmol FFA released/ml serum/h). For each experiment, PHLA was measured for 2 h after the first bolus heparin injection, for 4 h after the second bolus heparin, and for 1 h after the last bolus heparin administration. The end point for each heparin administration given is the result of data obtained on the first part of the study. The same group of animals were studied 24 h later, when bolus heparin was given at zero time (first) and I and 4 h after the first heparin administration. The halflife of circulating lipase increased from 30.6 min after the first bolus of heparin to 65.5 min after a second bolus of heparin given 60 min after the first injection. After a third bolus of heparin, given 4 h after the first bolus, the half-life of lipase in the circulation was 70 min. maximum PHLA release (53 pmol FFA releasedlml serum/h) occurred 10 min after IV administration of heparin. The peak response to repeated heparin administration at 1 and 4 h was similar to that elicited by the initial heparin dose. A noteworthy effect of the repeated administration of heparin was the marked increase in the half-life of the enzyme in the circulation from 30 to 70 min (Fig. 3) .
There was no significant difference between lipase levels in the weaning, the level of activity increasing almost 3-fold between 28 and 60 days of age. Our finding in the developing rat, that the release of endothelial lipoprotein lipase and hepatic lipase to the circulation following heparin injection does not lower the tissue enzyme concentrations, might be relevant to the clinical management of preterm infants. Very low birth weight infants (gestational age, 25-30 wk) often have to be kept on total parenteral nutrition containing Intralipid (a stable soybean oil emulsion) as the main energy source. We have recently shown that when the IV fluids contain low levels of heparin (1 unit/ml heparin added to prevent clotting of catheters), there are measurable levels of circulating lipase that might be associated with more efficient clearing of the Intralipid (25) . Our animal studies suggest that even higher amounts of heparin do not cause a significant depletion of tissue lipase stores. Furthermore, in the adult, the endothelial sites are rapidly replenished after initial release of lipoprotein lipase to the circulation. Whether the rate of endothelial lipase replenishment is similar in the newborn remains to be established.
